ARCHIVES

NIH Emerges From Republican Revolution With Another Increase in Appropriations

This article is from The Cancer Letter archive.

Vol. 22 No. 38 | October 4, 1996

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001

Bill Clinton, NBCC establish fund to honor former President’s late mother.

November 11, 2005